Statement on Pricing Transparency

AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:

AHRMM supports the concept of pricing transparency. Healthcare supply chain professionals should be able to purchase products after careful consideration of market conditions. This insight may be gained by benchmarking their existing and/or proposed prices against blinded benchmark prices being paid for those products by other hospitals. Purchasers, physicians, and hospital staff members who administer or use products and/or services should be able to gain access to the actual cost of the medical devices, purchased and leased equipment, and supplies that they, their insurance providers, or the government will be asked to cover, whether it is a direct charge or included in a DRG or CPT payment. No contract should contain confidentiality language that would preclude hospitals from sharing their prices in a blinded process with a third party to benchmark prices. Additionally, hospital purchasing staff should have the ability to acquire blinded benchmark pricing from GPOs, consultants, and other third parties offering that service. Hospital purchasing and contracting staff members should be able to use that information to negotiate in good faith with suppliers.

Related Resources

On-Demand Educational Webinars
An integrated culture, best in class supply chain practices, and data-driven insights all maximize savings and make a difference in health care…
Podcasts
Brent Petty discusses what forces are currently affecting healthcare and the platform hospitals use for decision making criteria.
Podcasts
Discover tips that can separate a health system’s success or failure when creating a viable purchased services sourcing program in this short video
On-Demand Educational Webinars
Advocate Health Care developed a provider-supplier partnership that reduced re-admission rates and improved quality of care inside and outside of the…
Podcasts
Michael Neely introduces the topic of risk sharing as it is becoming more popular in healthcare and how it can improve patient care while lowering
Podcasts
In this informational session, Karen Conway discusses her research with the FDA on value and the UDI.